Developer docs
API playgroundTry for free, no card

Search company profiles

YewMaker

Full company profile

uuid0005b6t

Namestring
YewMaker
Legal namestring
YewMaker
Websiteurl
yewmaker.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

YewMaker is a London-based, privately held company that builds science-based solutions to measure and reduce the carbon footprint of medicines. Founded by Dr Nazneen Rahman (CEO), the company operates the Sustainable Medicines Partnership (SMP), a not-for-profit, public-private action collaborative of 48 organisations spanning pharma manufacturers, generics, retail, distributors, supply chain, technology providers, healthcare providers, hospitals, pharmacy, academia, and policymakers. Its flagship technology is MCF Classifier, an AI-driven data suite that estimates the cradle-to-gate carbon footprint of active pharmaceutical ingredients by combining molecular weight, chemical structure, and Process Mass Intensity (PMI) into standardised emissions ratings (LOW/MEDIUM/HIGH/VERY HIGH), compliant with GHG Protocol, PAS, and ISO standards. The MCF Method has been published in peer-reviewed journals (British Journal of Clinical Pharmacology; BMJ Open; Journal of Climate Change and Health).

The company's product surface includes the free MCF Formulary web application (per-dose ratings for over 4,000 medicines), the MCF Product Dataset (CO2e values for over 30,000 products on Zenodo), the MCF API Dataset, and research outputs such as the 'Every Dose Used' Playbook and Sustainable Blister Packaging Eco-Design Report. YewMaker serves healthcare professionals, pharmaceutical manufacturers, policymakers, and researchers, but does not monetise its core products commercially; instead, development has been supported by NHS pilot and SBRI Healthcare grants (totalling approximately £730K disclosed across 2022 and 2023). The current headcount is 1-10 employees, indicating an early-stage, mission-driven operating model reliant on grant funding and the multi-stakeholder SMP network for distribution.

Short descriptiontext

YewMaker builds AI-driven tools that standardise medicine carbon footprints across more than 30,000 products. Led by Dr Nazneen Rahman, the London-based company operates the Sustainable Medicines Partnership of 48 organisations and is primarily NHS grant-funded.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
sustainable medicines, medicine carbon footprinting, pharmaceutical sustainability, healthcare decarbonization analytics, medicines waste reduction
Industry3 codes
PRIMARYEUABAEAD
Emissions Factors, LCA & Product Carbon Footprint (PCF) Platforms
Energy, Utilities & Environment/Carbon & Climate Solutions (Carbon Markets, Offsets, CCS/CCUS)/Carbon Accounting, Reporting & Climate Data Platforms (GHG Inventories, ESG/Disclosure)
SECONDARYEUABAEAA
Enterprise Carbon Accounting & GHG Inventory Platforms
Energy, Utilities & Environment/Carbon & Climate Solutions (Carbon Markets, Offsets, CCS/CCUS)/Carbon Accounting, Reporting & Climate Data Platforms (GHG Inventories, ESG/Disclosure)
SECONDARYEUABAEAB
ESG/Sustainability Reporting & Disclosure Platforms
Energy, Utilities & Environment/Carbon & Climate Solutions (Carbon Markets, Offsets, CCS/CCUS)/Carbon Accounting, Reporting & Climate Data Platforms (GHG Inventories, ESG/Disclosure)
NAICS code1 code
  • Software Publishers5132
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Healthcare Sustainability Analytics
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Grant Funding / SBRI Healthcare
TypeSubscription Recurring
Description

YewMaker has received NHS funding (£730K from Accelerated Access Collaborative through SBRI Healthcare) and pilot funding to build MCF Classifier as user-friendly software supporting carbon-informed medicines use.

yewmaker.com
2Free Thought Leadership & Product Suite
TypeFreemium
Description

Core products including MCF Formulary, datasets, eBooks, and playbooks are offered free of charge as educational resources to drive adoption of sustainable medicines practices. Revenue model appears grant-funded rather than commercial at this stage.

yewmaker.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
Pricing details1 tier
1Free access to all core products
ModelFreemiumBilling cadencePay-as-you-go
Notes

MCF Formulary, MCF Product Dataset, MCF API Dataset, eBook, Playbook, Reports, and Webinars are all freely accessible. No commercial pricing tiers are listed.

yewmaker.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

YewMaker builds science-based software to measure and reduce the carbon footprint of medicines. Its flagship product, MCF Classifier, is an AI-driven data suite that produces standardised cradle-to-gate carbon footprint ratings for active pharmaceutical ingredients. The MCF Formulary web app and MCF Product Dataset make these ratings accessible to healthcare professionals, pharmaceutical manufacturers, and researchers, supporting carbon-informed prescribing, procurement, and ESG reporting. YewMaker also operates the Sustainable Medicines Partnership (SMP), a 48-organisation multi-stakeholder action collaborative executing a four-year programme to reduce medicine waste.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 140,000 tonnes CO2e total footprint for 2.2 billion NHS England prescribed doses analysed (January 2023)
+4 more records
Product overview1 text field

YewMaker offers a suite of science-based healthcare sustainability products centered around the MCF Classifier platform. The core offering includes MCF Classifier—an AI-driven data suite for medicine carbon emissions—comprising the free MCF Formulary web application for browsing over 4,000 medicine carbon ratings, the MCF Product Dataset covering 30,000+ medicine products, and the MCF API Dataset for programmatic access. Complementing the data platform, YewMaker leads the Sustainable Medicines Partnership (SMP), an action collaborative of 48 organizations, and produces thought leadership content including the 'Every Dose Used' Playbook, Sustainable Blister Packaging Eco-Design Report, and peer-reviewed research papers on medicine carbon footprints and decarbonization strategies.

Product and service5 records
1MCF Classifier
CategoryHealthcare sustainability analytics software
Description

AI-driven data suite that produces standardised cradle-to-gate carbon footprint ratings (LOW, MEDIUM, HIGH, VERY HIGH) for medicines, compliant with GHG Protocol, PAS, and ISO standards and grounded in Process Mass Intensity.

2MCF Formulary
CategoryMedicine carbon footprint web application
Description

Free interactive web application providing searchable per-dose carbon footprint ratings for over 4,000 medicines, aimed at healthcare professionals, pharmaceutical manufacturers, and supply chain professionals.

3MCF Product Dataset
CategoryMedicine carbon footprint data product
Description

Comprehensive dataset containing MCF Ratings and CO2e values for more than 30,000 medicine products, distributed via the Zenodo open data repository with DOI.

4MCF API Dataset
CategoryMedicine carbon footprint data product
Description

API-formatted dataset for medicine carbon footprint data, distributed via Zenodo for programmatic access by researchers and analysts.

5Sustainable Medicines Partnership (SMP)
CategoryMulti-stakeholder sustainability collaborative
Description

A not-for-profit, public-private, multi-stakeholder global action collaborative of 48 organisations executing a four-year programme to reduce waste of medicines and waste from medicines.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership29 partners
1AHSN (Academic Health Science Network)
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2023-02-08
Description

Collaborator on MCF Classifier project. National NetZero Lead Pete Waddingham led the MCF Classifier webinar. AHSN network supports adoption of innovation across the NHS.

yewmaker.com
2University Hospital Plymouth NHS Trust
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2023-02-08
Description

Collaborator on MCF Classifier project, providing clinical and operational insights for carbon-informed medicines use.

yewmaker.com
3Sustainable Medicines Partnership (SMP) - 48 Collaborating Organisations
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2022-10-05
Description

SMP is a not-for-profit, public-private, multi-stakeholder global action collaborative of 48 organisations executing a four-year programme to reduce waste of medicines and medicines packaging. Includes pharma, generics, retail, distributors, supply chain, technology, healthcare, hospitals, pharmacy, academia, and policymakers.

yewmaker.com
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2022-10-04
Description

Walgreens Boots Alliance joined the SMP as a collaborator. Major retail pharmacy operator bringing pharmacy, healthcare delivery, and supply chain expertise to sustainable medicines initiatives.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2022-10-04
Description

AstraZeneca participated in the SMP Founders Launch Event and Reuters Events webinar on sustainable medicines. Founding industry partner of the Medicines Manufacturing Innovation Centre (with CPI and GSK). Committed to sustainable pharmaceutical manufacturing.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2022-10-04
Description

GSK is a founding industry partner of the Medicines Manufacturing Innovation Centre (with CPI and AstraZeneca). Collaborates with SMP on sustainable medicines manufacturing, distribution, and disposal life cycles.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2022-10-04
Description

Deloitte partnered with SMP for the Reuters Events webinar on delivering meaningful change in sustainable medicines. SMP showcased at a Deloitte-sponsored panel. Deloitte published thought leadership on embedding environmental sustainability into pharma's DNA.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2022-10-04
Description

Pfizer participated in the SMP Founders Launch Event and Reuters Events expert panel on sustainable medicines alongside AstraZeneca and Deloitte.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-09-29
Description

Consilient Health joined as SMP Founding Collaborator. Medium-sized pharmaceutical company focused on women's health, endocrinology, bone health, and urology. Working across SMP projects to reduce carbon footprint and waste of medicines by providing data, practical insights, and expertise.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2022-09-26
Description

Haleon (LSE: HLN) joined as SMP Founding Collaborator. Global leader in consumer health with brands trusted by millions globally. Sustainability ambitions include reducing virgin petroleum-based plastic use by 10% by 2025 and 1/3 by 2030. Focuses on recycling and integrating rejected content into blister packs.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-09-23
Description

GOSH joined as SMP Founding Collaborator. A world-leading children's hospital and the first London Hospital to declare a Climate Emergency. Provides sustainable healthcare provider expertise and piloting insights for medicines sustainability.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-09-21
Description

Telesofia Medical joined as SMP Founding Collaborator. Developer of a patient engagement platform using patented personalised video technology. Supports the Digitising Medicines Information Project, leveraging an existing library of videos for over 11,000 medication products to reduce leaflet printing.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2022-09-07
Description

ABPI joined as SMP Founding Collaborator. Represents research-based pharmaceutical companies in the UK. Collaborating on reducing single-use plastics in medicines packaging and increasing digital medicines information.

14PAGB (Proprietary Association of Great Britain)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-09-01
Description

PAGB joined as SMP Founding Collaborator. Represents manufacturers of branded OTC medicines, self-care medical devices, and food supplements in the UK. Facilitates engagement with members on inclusive, accessible digital medicines information development.

yewmaker.com
15BGMA (British Generic Manufacturers Association)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-09-01
Description

BGMA joined as SMP Founding Collaborator. Represents the UK generic medicines industry which saves the NHS £15 billion annually via competition. Represents and facilitates engagement with members on projects to reduce environmental impact of medicines manufacture, packaging, distribution, and destruction.

yewmaker.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-08-31
Description

GS1 Healthcare joined as SMP Founding Collaborator. Neutral, not-for-profit global organisation developing the most widely used supply chain standards system. Provides expertise on using global standards to create visibility of every step of the medicines lifecycle from manufacture to patient, crucial for minimising wastage and improving accessibility.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2022-08-24
Description

CPI joined as SMP Founding Collaborator. Accelerates development, scale-up and commercialisation of deep tech and sustainable manufacturing solutions including next-generation medicine manufacturing. Home to the Medicines Manufacturing Innovation Centre in Renfrewshire, Scotland, in collaboration with CPI, University of Strathclyde, AstraZeneca, and GSK.

18NW Greener NHS
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2022-07-05
Description

NW Greener NHS joined as SMP Founding Collaborator. Part of NHS England North West regional team, one of seven regional teams delivering the Greener NHS Programme. Supports projects to measure medicine carbon footprints and identify opportunities for optimising medicines use across 32 NHS Trusts.

yewmaker.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-06-22
Description

VHA VIONE Team joined as SMP Collaborator. VHA is the largest integrated Health Care System in the USA with over 1,298 medical facilities. VIONE is a medication optimisation and polypharmacy reduction programme that has deprescribed over 1 million potentially inappropriate medications, achieving $94 million cost avoidance.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-06-14
Description

Newcastle Hospitals joined as SMP Founding Collaborator. One of the UK's largest NHS Trusts with ~17,000 staff and 1.8 million patient contacts per year. First healthcare organisation in the world to declare a Climate Emergency. Provides sustainable healthcare provider expertise to inform and develop medicines sustainability solutions.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-05-24
Description

nVentic joined as SMP Founding Collaborator. Specialist inventory optimisation company using advanced mathematical techniques. Leverages analytical capabilities to support frameworks for improving medicine availability and reducing excess inventory that gets destroyed. Expert on pharmaceutical inventory write-offs.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2022-05-10
Description

PA Consulting joined as SMP Founding Collaborator. Innovation and transformation consultancy working across the healthcare and life sciences ecosystem. Applying pharma and sustainability expertise and capabilities to SMP projects, working with like-minded collaborators to deliver a more sustainable future.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-04-05
Description

Liveo Research joined as SMP Founding Collaborator. Leading global manufacturer of films and foils for pharmaceutical blister packaging, headquartered in Basel, Switzerland. Supports research and pilots in advanced recycling of pharmaceutical blister packaging and maximising shelf life of medicines.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-03-29
Description

Datapharm joined as SMP Founding Collaborator. Healthcare technology company providing the emc medicines information website with 145 million+ views annually. Supports the Digitising Medicines Information Project with insight into electronic patient information leaflet adoption.

25myHealthbox
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-03-29
Description

myHealthbox joined as SMP Founding Collaborator. Leading provider of digital solutions making information on medicines more accessible. Supports the Digitising Medicines Information Project; eLeaflet solution is the first electronic Product Information platform for creation, validation and distribution of digital leaflets for medicines.

yewmaker.com
26Sustainable Healthcare Coalition
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-03-22
Description

Sustainable Healthcare Coalition joined as SMP Founding Collaborator. Not-for-profit healthcare sector group created by NHS England to inspire sustainable practices. Fiona Adshead (SHC Chair) also joined SMP Executive team as Senior Policy Lead.

yewmaker.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-03-15
Description

Jones Healthcare Group joined as SMP Founding Collaborator. Global provider of advanced packaging and medication dispensing solutions with over a century of regulated healthcare packaging expertise. Developing multi-platform frameworks including digital-first prototypes for medicines information and sustainable packaging innovations.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-03-07
Description

Agilyx (Euronext Growth Oslo: AGLX) joined as SMP Founding Collaborator. Technology company enabling customers to recycle difficult-to-recycle post-use plastics. Focus on enhancing medicines packaging sustainability; approximately 1 trillion medicine packets are thrown away each year.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-03-02
Description

WPO joined as SMP Founding Collaborator. A non-profit global federation of national packaging institutes promoting education and excellence in packaging. Endorses SMP Awards within the WorldStar Packaging Awards programme.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Enterprise ESG and product sustainability software platform covering GHG inventories, Scope 3, and product carbon footprints across industries. Comparable to YewMaker as a broad-based carbon/LCA software incumbent that any pharma counterparty could choose over MCF Classifier.

TypeDirect peer
Description

Cloud-based LCA and product carbon footprint platform used by consumer goods and pharmaceutical manufacturers to model cradle-to-gate footprints. Directly comparable to MCF Classifier on the product carbon footprint / emissions-factor methodology that YewMaker applies to medicines.

TypeDirect peer
Description

Developer of SimaPro, a long-established professional LCA software platform used globally for product carbon footprinting and life cycle assessment. Comparable as an alternative tool path for pharma manufacturers who need standardized PCF calculation rather than a verticalized formulary view.

TypeEmerging player
Description

AI-enabled climate management and accounting platform for enterprise Scope 1–3 emissions. Comparable as a newer-generation carbon accounting platform that could be extended into pharma-specific product footprints.

TypeEmerging player
Description

Enterprise carbon accounting platform focused on measurement, reporting and reduction. Comparable as a competing platform pharma ESG teams might procure instead of building on MCF Classifier data.

TypeBroad incumbent
Description

Large climate consultancy and solutions provider running corporate decarbonization programmes across pharma and healthcare. Comparable as an established incumbent that incumbent pharma companies typically engage for sustainability programmes that YewMaker is also targeting.

TypeBroad incumbent
Description

Sustainability consultancy and product carbon footprint certifier working extensively with pharma and FMCG companies. Comparable as a credible alternative pathway for procurement of PCF/LCA services in the medicines sector.

TypeBroad incumbent
Description

Cloud platform for ESG and sustainability disclosure reporting aligned to CSRD, SEC and other regimes. Comparable as a competing destination for pharma ESG reporting budgets and as a potential channel/distribution risk if it integrates carbon product data.

TypeEmerging player
Description

Non-profit focused on laboratory and life-science sustainability, with programmes overlapping healthcare R&D decarbonization. Comparable as an adjacent healthcare sustainability ecosystem player with whom YewMaker could partner or by which it could be supplanted in life-science settings.

10Sustainable Healthcare Coalition
TypeOthers
Description

NHS-convened healthcare sector coalition driving sustainable practices across providers and suppliers. Already a SMP collaborator; relevant because it is the natural policy/thought-leadership peer and an obvious go-to-market partner or overlap area for YewMaker's mission.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

YewMaker

Healthcare Sustainability Analyticsyewmaker.com

YewMaker builds AI-driven tools that standardise medicine carbon footprints across more than 30,000 products. Led by Dr Nazneen Rahman, the London-based company operates the Sustainable Medicines Partnership of 48 organisations and is primarily NHS grant-funded.

What YewMaker does

YewMaker is a London-based, privately held company that builds science-based solutions to measure and reduce the carbon footprint of medicines. Founded by Dr Nazneen Rahman (CEO), the company operates the Sustainable Medicines Partnership (SMP), a not-for-profit, public-private action collaborative of 48 organisations spanning pharma manufacturers, generics, retail, distributors, supply chain, technology providers, healthcare providers, hospitals, pharmacy, academia, and policymakers. Its flagship technology is MCF Classifier, an AI-driven data suite that estimates the cradle-to-gate carbon footprint of active pharmaceutical ingredients by combining molecular weight, chemical structure, and Process Mass Intensity (PMI) into standardised emissions ratings (LOW/MEDIUM/HIGH/VERY HIGH), compliant with GHG Protocol, PAS, and ISO standards. The MCF Method has been published in peer-reviewed journals (British Journal of Clinical Pharmacology; BMJ Open; Journal of Climate Change and Health).

The company's product surface includes the free MCF Formulary web application (per-dose ratings for over 4,000 medicines), the MCF Product Dataset (CO2e values for over 30,000 products on Zenodo), the MCF API Dataset, and research outputs such as the 'Every Dose Used' Playbook and Sustainable Blister Packaging Eco-Design Report. YewMaker serves healthcare professionals, pharmaceutical manufacturers, policymakers, and researchers, but does not monetise its core products commercially; instead, development has been supported by NHS pilot and SBRI Healthcare grants (totalling approximately £730K disclosed across 2022 and 2023). The current headcount is 1-10 employees, indicating an early-stage, mission-driven operating model reliant on grant funding and the multi-stakeholder SMP network for distribution.

YewMaker firmographics

Firmographics
Name
YewMaker
Legal name
YewMaker
Website
https://yewmaker.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
1–10 employees
Short description
YewMaker builds AI-driven tools that standardise medicine carbon footprints across more than 30,000 products. Led by Dr Nazneen Rahman, the London-based company operates the Sustainable Medicines Partnership of 48 organisations and is primarily NHS grant-funded.
Ownership category
akta.pro rank

YewMaker industry classification

Industry
Product category
Healthcare Sustainability Analytics
NAICS
Software Publishers (5132)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYEUABAEAD
Emissions Factors, LCA & Product Carbon Footprint (PCF) Platforms
Energy, Utilities & Environment/Carbon & Climate Solutions (Carbon Markets, Offsets, CCS/CCUS)/Carbon Accounting, Reporting & Climate Data Platforms (GHG Inventories, ESG/Disclosure)
SECONDARYEUABAEAA
Enterprise Carbon Accounting & GHG Inventory Platforms
Energy, Utilities & Environment/Carbon & Climate Solutions (Carbon Markets, Offsets, CCS/CCUS)/Carbon Accounting, Reporting & Climate Data Platforms (GHG Inventories, ESG/Disclosure)
SECONDARYEUABAEAB
ESG/Sustainability Reporting & Disclosure Platforms
Energy, Utilities & Environment/Carbon & Climate Solutions (Carbon Markets, Offsets, CCS/CCUS)/Carbon Accounting, Reporting & Climate Data Platforms (GHG Inventories, ESG/Disclosure)

Keywords

  • Sustainable medicines
  • Medicine carbon footprinting
  • Pharmaceutical sustainability
  • Healthcare decarbonization analytics
  • Medicines waste reduction

Where YewMaker is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Markets served

YewMaker business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Grant Funding / SBRI Healthcare: YewMaker has received NHS funding (£730K from Accelerated Access Collaborative through SBRI Healthcare) and pilot funding to build MCF Classifier as user-friendly software supporting carbon-informed medicines use.
  2. Free Thought Leadership & Product Suite: Core products including MCF Formulary, datasets, eBooks, and playbooks are offered free of charge as educational resources to drive adoption of sustainable medicines practices. Revenue model appears grant-funded rather than commercial at this stage.

Pricing tiers

ModelBillingPrice
FreemiumPay-as-you-goFree access to all core products

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

YewMaker product offering

Product offering

Core offering

YewMaker builds science-based software to measure and reduce the carbon footprint of medicines. Its flagship product, MCF Classifier, is an AI-driven data suite that produces standardised cradle-to-gate carbon footprint ratings for active pharmaceutical ingredients. The MCF Formulary web app and MCF Product Dataset make these ratings accessible to healthcare professionals, pharmaceutical manufacturers, and researchers, supporting carbon-informed prescribing, procurement, and ESG reporting. YewMaker also operates the Sustainable Medicines Partnership (SMP), a 48-organisation multi-stakeholder action collaborative executing a four-year programme to reduce medicine waste.

Product overview

YewMaker offers a suite of science-based healthcare sustainability products centered around the MCF Classifier platform. The core offering includes MCF Classifier—an AI-driven data suite for medicine carbon emissions—comprising the free MCF Formulary web application for browsing over 4,000 medicine carbon ratings, the MCF Product Dataset covering 30,000+ medicine products, and the MCF API Dataset for programmatic access. Complementing the data platform, YewMaker leads the Sustainable Medicines Partnership (SMP), an action collaborative of 48 organizations, and produces thought leadership content including the 'Every Dose Used' Playbook, Sustainable Blister Packaging Eco-Design Report, and peer-reviewed research papers on medicine carbon footprints and decarbonization strategies.

Differentiator

Problem solved

Functional benefit

Products and services

  • MCF Classifier AI-driven data suite that produces standardised cradle-to-gate carbon footprint ratings (LOW, MEDIUM, HIGH, VERY HIGH) for medicines, compliant with GHG Protocol, PAS, and ISO standards and grounded in Process Mass Intensity.
  • MCF Formulary Free interactive web application providing searchable per-dose carbon footprint ratings for over 4,000 medicines, aimed at healthcare professionals, pharmaceutical manufacturers, and supply chain professionals.
  • MCF Product Dataset Comprehensive dataset containing MCF Ratings and CO2e values for more than 30,000 medicine products, distributed via the Zenodo open data repository with DOI.
  • MCF API Dataset API-formatted dataset for medicine carbon footprint data, distributed via Zenodo for programmatic access by researchers and analysts.
  • Sustainable Medicines Partnership (SMP) A not-for-profit, public-private, multi-stakeholder global action collaborative of 48 organisations executing a four-year programme to reduce waste of medicines and waste from medicines.

Quantifiable outcome

  • 140,000 tonnes CO2e total footprint for 2.2 billion NHS England prescribed doses analysed (January 2023)
  • +4 more outcomes

Companies that use YewMaker

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles3 records

YewMaker technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

YewMaker partnerships and signals

Strategic signal

Partnerships

29 partnerships are on record, tiered major, flagship and core.

  • AHSN (Academic Health Science Network)majorStrategic or Co-development Partner · 8 February 2023Collaborator on MCF Classifier project. National NetZero Lead Pete Waddingham led the MCF Classifier webinar. AHSN network supports adoption of innovation across the NHS.
  • University Hospital Plymouth NHS TrustmajorStrategic or Co-development Partner · 8 February 2023Collaborator on MCF Classifier project, providing clinical and operational insights for carbon-informed medicines use.
  • Sustainable Medicines Partnership (SMP) - 48 Collaborating OrganisationsflagshipStrategic or Co-development Partner · 5 October 2022SMP is a not-for-profit, public-private, multi-stakeholder global action collaborative of 48 organisations executing a four-year programme to reduce waste of medicines and medicines packaging. Includes pharma, generics, retail, distributors, supply chain, technology, healthcare, hospitals, pharmacy, academia, and policymakers.
  • Walgreens Boots AlliancemajorStrategic or Co-development Partner · 4 October 2022Walgreens Boots Alliance joined the SMP as a collaborator. Major retail pharmacy operator bringing pharmacy, healthcare delivery, and supply chain expertise to sustainable medicines initiatives.
  • AstraZenecamajorStrategic or Co-development Partner · 4 October 2022AstraZeneca participated in the SMP Founders Launch Event and Reuters Events webinar on sustainable medicines. Founding industry partner of the Medicines Manufacturing Innovation Centre (with CPI and GSK). Committed to sustainable pharmaceutical manufacturing.
  • GSKmajorStrategic or Co-development Partner · 4 October 2022GSK is a founding industry partner of the Medicines Manufacturing Innovation Centre (with CPI and AstraZeneca). Collaborates with SMP on sustainable medicines manufacturing, distribution, and disposal life cycles.
  • DeloittemajorStrategic or Co-development Partner · 4 October 2022Deloitte partnered with SMP for the Reuters Events webinar on delivering meaningful change in sustainable medicines. SMP showcased at a Deloitte-sponsored panel. Deloitte published thought leadership on embedding environmental sustainability into pharma's DNA.
  • PfizermajorStrategic or Co-development Partner · 4 October 2022Pfizer participated in the SMP Founders Launch Event and Reuters Events expert panel on sustainable medicines alongside AstraZeneca and Deloitte.
  • Consilient HealthcoreStrategic or Co-development Partner · 29 September 2022Consilient Health joined as SMP Founding Collaborator. Medium-sized pharmaceutical company focused on women's health, endocrinology, bone health, and urology. Working across SMP projects to reduce carbon footprint and waste of medicines by providing data, practical insights, and expertise.
  • HaleonmajorStrategic or Co-development Partner · 26 September 2022Haleon (LSE: HLN) joined as SMP Founding Collaborator. Global leader in consumer health with brands trusted by millions globally. Sustainability ambitions include reducing virgin petroleum-based plastic use by 10% by 2025 and 1/3 by 2030. Focuses on recycling and integrating rejected content into blister packs.
  • Great Ormond Street Hospital for Children (GOSH)coreStrategic or Co-development Partner · 23 September 2022GOSH joined as SMP Founding Collaborator. A world-leading children's hospital and the first London Hospital to declare a Climate Emergency. Provides sustainable healthcare provider expertise and piloting insights for medicines sustainability.
  • Telesofia MedicalcoreStrategic or Co-development Partner · 21 September 2022Telesofia Medical joined as SMP Founding Collaborator. Developer of a patient engagement platform using patented personalised video technology. Supports the Digitising Medicines Information Project, leveraging an existing library of videos for over 11,000 medication products to reduce leaflet printing.
  • ABPI (Association of the British Pharmaceutical Industry)majorStrategic or Co-development Partner · 7 September 2022ABPI joined as SMP Founding Collaborator. Represents research-based pharmaceutical companies in the UK. Collaborating on reducing single-use plastics in medicines packaging and increasing digital medicines information.
  • PAGB (Proprietary Association of Great Britain)coreStrategic or Co-development Partner · 1 September 2022PAGB joined as SMP Founding Collaborator. Represents manufacturers of branded OTC medicines, self-care medical devices, and food supplements in the UK. Facilitates engagement with members on inclusive, accessible digital medicines information development.
  • BGMA (British Generic Manufacturers Association)coreStrategic or Co-development Partner · 1 September 2022BGMA joined as SMP Founding Collaborator. Represents the UK generic medicines industry which saves the NHS £15 billion annually via competition. Represents and facilitates engagement with members on projects to reduce environmental impact of medicines manufacture, packaging, distribution, and destruction.
  • GS1 HealthcarecoreStrategic or Co-development Partner · 31 August 2022GS1 Healthcare joined as SMP Founding Collaborator. Neutral, not-for-profit global organisation developing the most widely used supply chain standards system. Provides expertise on using global standards to create visibility of every step of the medicines lifecycle from manufacture to patient, crucial for minimising wastage and improving accessibility.
  • CPI (Centre for Process Innovation)majorStrategic or Co-development Partner · 24 August 2022CPI joined as SMP Founding Collaborator. Accelerates development, scale-up and commercialisation of deep tech and sustainable manufacturing solutions including next-generation medicine manufacturing. Home to the Medicines Manufacturing Innovation Centre in Renfrewshire, Scotland, in collaboration with CPI, University of Strathclyde, AstraZeneca, and GSK.
  • NW Greener NHSmajorStrategic or Co-development Partner · 5 July 2022NW Greener NHS joined as SMP Founding Collaborator. Part of NHS England North West regional team, one of seven regional teams delivering the Greener NHS Programme. Supports projects to measure medicine carbon footprints and identify opportunities for optimising medicines use across 32 NHS Trusts.
  • Veterans Health Administration 'VIONE'coreStrategic or Co-development Partner · 22 June 2022VHA VIONE Team joined as SMP Collaborator. VHA is the largest integrated Health Care System in the USA with over 1,298 medical facilities. VIONE is a medication optimisation and polypharmacy reduction programme that has deprescribed over 1 million potentially inappropriate medications, achieving $94 million cost avoidance.
  • Newcastle Hospitals NHS Foundation TrustcoreStrategic or Co-development Partner · 14 June 2022Newcastle Hospitals joined as SMP Founding Collaborator. One of the UK's largest NHS Trusts with ~17,000 staff and 1.8 million patient contacts per year. First healthcare organisation in the world to declare a Climate Emergency. Provides sustainable healthcare provider expertise to inform and develop medicines sustainability solutions.
  • nVenticcoreStrategic or Co-development Partner · 24 May 2022nVentic joined as SMP Founding Collaborator. Specialist inventory optimisation company using advanced mathematical techniques. Leverages analytical capabilities to support frameworks for improving medicine availability and reducing excess inventory that gets destroyed. Expert on pharmaceutical inventory write-offs.
  • PA ConsultingmajorStrategic or Co-development Partner · 10 May 2022PA Consulting joined as SMP Founding Collaborator. Innovation and transformation consultancy working across the healthcare and life sciences ecosystem. Applying pharma and sustainability expertise and capabilities to SMP projects, working with like-minded collaborators to deliver a more sustainable future.
  • Liveo ResearchcoreStrategic or Co-development Partner · 5 April 2022Liveo Research joined as SMP Founding Collaborator. Leading global manufacturer of films and foils for pharmaceutical blister packaging, headquartered in Basel, Switzerland. Supports research and pilots in advanced recycling of pharmaceutical blister packaging and maximising shelf life of medicines.
  • DatapharmcoreStrategic or Co-development Partner · 29 March 2022Datapharm joined as SMP Founding Collaborator. Healthcare technology company providing the emc medicines information website with 145 million+ views annually. Supports the Digitising Medicines Information Project with insight into electronic patient information leaflet adoption.
  • myHealthboxcoreStrategic or Co-development Partner · 29 March 2022myHealthbox joined as SMP Founding Collaborator. Leading provider of digital solutions making information on medicines more accessible. Supports the Digitising Medicines Information Project; eLeaflet solution is the first electronic Product Information platform for creation, validation and distribution of digital leaflets for medicines.
  • Sustainable Healthcare CoalitioncoreStrategic or Co-development Partner · 22 March 2022Sustainable Healthcare Coalition joined as SMP Founding Collaborator. Not-for-profit healthcare sector group created by NHS England to inspire sustainable practices. Fiona Adshead (SHC Chair) also joined SMP Executive team as Senior Policy Lead.
  • Jones Healthcare GroupcoreStrategic or Co-development Partner · 15 March 2022Jones Healthcare Group joined as SMP Founding Collaborator. Global provider of advanced packaging and medication dispensing solutions with over a century of regulated healthcare packaging expertise. Developing multi-platform frameworks including digital-first prototypes for medicines information and sustainable packaging innovations.
  • AgilyxcoreStrategic or Co-development Partner · 7 March 2022Agilyx (Euronext Growth Oslo: AGLX) joined as SMP Founding Collaborator. Technology company enabling customers to recycle difficult-to-recycle post-use plastics. Focus on enhancing medicines packaging sustainability; approximately 1 trillion medicine packets are thrown away each year.
  • World Packaging Organisation (WPO)coreStrategic or Co-development Partner · 2 March 2022WPO joined as SMP Founding Collaborator. A non-profit global federation of national packaging institutes promoting education and excellence in packaging. Endorses SMP Awards within the WorldStar Packaging Awards programme.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

YewMaker competitors and assessment

Company assessment

Broad incumbents

  • Sphera: Enterprise ESG and product sustainability software platform covering GHG inventories, Scope 3, and product carbon footprints across industries. Comparable to YewMaker as a broad-based carbon/LCA software incumbent that any pharma counterparty could choose over MCF Classifier.
  • South Pole Group: Large climate consultancy and solutions provider running corporate decarbonization programmes across pharma and healthcare. Comparable as an established incumbent that incumbent pharma companies typically engage for sustainability programmes that YewMaker is also targeting.
  • Carbon Trust: Sustainability consultancy and product carbon footprint certifier working extensively with pharma and FMCG companies. Comparable as a credible alternative pathway for procurement of PCF/LCA services in the medicines sector.
  • Workiva: Cloud platform for ESG and sustainability disclosure reporting aligned to CSRD, SEC and other regimes. Comparable as a competing destination for pharma ESG reporting budgets and as a potential channel/distribution risk if it integrates carbon product data.

Direct peers

  • Ecochain: Cloud-based LCA and product carbon footprint platform used by consumer goods and pharmaceutical manufacturers to model cradle-to-gate footprints. Directly comparable to MCF Classifier on the product carbon footprint / emissions-factor methodology that YewMaker applies to medicines.
  • PRé Sustainability (SimaPro): Developer of SimaPro, a long-established professional LCA software platform used globally for product carbon footprinting and life cycle assessment. Comparable as an alternative tool path for pharma manufacturers who need standardized PCF calculation rather than a verticalized formulary view.

Emerging players

  • Persefoni: AI-enabled climate management and accounting platform for enterprise Scope 1–3 emissions. Comparable as a newer-generation carbon accounting platform that could be extended into pharma-specific product footprints.
  • Watershed: Enterprise carbon accounting platform focused on measurement, reporting and reduction. Comparable as a competing platform pharma ESG teams might procure instead of building on MCF Classifier data.
  • My Green Lab: Non-profit focused on laboratory and life-science sustainability, with programmes overlapping healthcare R&D decarbonization. Comparable as an adjacent healthcare sustainability ecosystem player with whom YewMaker could partner or by which it could be supplanted in life-science settings.

Others

  • Sustainable Healthcare Coalition: NHS-convened healthcare sector coalition driving sustainable practices across providers and suppliers. Already a SMP collaborator; relevant because it is the natural policy/thought-leadership peer and an obvious go-to-market partner or overlap area for YewMaker's mission.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

YewMaker social profiles

Digital presence

YewMaker financial estimates

Financial estimate

Revenue estimate

Valuation estimate

YewMaker leadership team

Management profile

Number of profiles

Profiles2 records

YewMaker funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

YewMaker M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about YewMaker

What does YewMaker do?

YewMaker builds science-based software to measure and reduce the carbon footprint of medicines. Its flagship product, MCF Classifier, is an AI-driven data suite that produces standardised cradle-to-gate carbon footprint ratings for active pharmaceutical ingredients. The MCF Formulary web app and MCF Product Dataset make these ratings accessible to healthcare professionals, pharmaceutical manufacturers, and researchers, supporting carbon-informed prescribing, procurement, and ESG reporting. YewMaker also operates the Sustainable Medicines Partnership (SMP), a 48-organisation multi-stakeholder action collaborative executing a four-year programme to reduce medicine waste.

Is YewMaker a public or private company?

YewMaker is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was YewMaker founded?

YewMaker was founded in 2018. It employs 1 to 10 people.

Where is YewMaker based?

YewMaker is headquartered in London, United Kingdom, in the Europe region.

How does YewMaker make money?

Two revenue lines are on record. Grant Funding / SBRI Healthcare is the primary driver. The others are free Thought Leadership & Product Suite.

Who are YewMaker's main competitors?

Broad incumbents on record are Sphera, South Pole Group, Carbon Trust and Workiva. Direct peers are Ecochain and PRé Sustainability (SimaPro). Emerging players are Persefoni, Watershed and My Green Lab. Sustainable Healthcare Coalition is listed as an others.

Does YewMaker have an API?

No public API is recorded for YewMaker.

What industry is YewMaker in?

YewMaker's product category is Healthcare Sustainability Analytics. Its primary akta.pro industry code is EUABAEAD, Emissions Factors, LCA & Product Carbon Footprint (PCF) Platforms, with a secondary code of EUABAEAA, Enterprise Carbon Accounting & GHG Inventory Platforms. Its NAICS code is 5132 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales